BACK TO ALL STUDIES

Fort Bragg, NC: Paratrooper Point Prevalence Study (Round 2)

PRIMARY OBJECTIVE(s)

To determine the exposure of Soldiers to SARS-CoV-2 via antibody testing during Phase 1 of reopening.

PRINCIPAL INVESTIGATOR(S)

Sammy Choi

CONTACT
Sammy Choi
young.s.choi.civ@mail.mil
TREATMENT/CLINICAL & LAB INVESTIGATION

No treatment. SARS-CoV-2 antibody testing.

POPULATION
Fort Bragg active duty Soldiers
FULL NAME OF DIAGNOSTIC TEST
Lab Used for Diagnostic Test
Full Name of Serology/Antibody Test

SARS-CoV-2 IgG assay on the ARCHTEXT i2000 system.

Lab Used for Serology/Antibody Test
IgG through LabCorp
Want more information about this study?
study website